Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Obstructive sleep apnoea: from pathogenesis to treatment: current controversies and future directions|
|Citation:||Respirology, 2010; 15(4):587-595|
|Publisher:||Blackwell Publishing Asia|
|Peter R. Eastwood, Atul Malhotra, Lyle J. Palmer, Eric J. Kezirian, Richard L. Horner, Mary S. Ip, Robert Thurnheer, Nick A. Antic and David R. Hillman|
|Abstract:||Obstructive sleep apnoea (OSA) is a common disease, recognized as an independent risk factor for a range of clinical conditions, such as hypertension, stroke, depression and diabetes. Despite extensive research over the past two decades, the mechanistic links between OSA and other associated clinical conditions, including metabolic disorders and cardiovascular disease, remain unclear. Indeed, the pathogenesis of OSA itself remains incompletely understood. This review provides opinions from a number of leading experts on issues related to OSA and its pathogenesis, interaction with anaesthesia, metabolic consequences and comorbidities, cardiovascular disease, genetics, measurement and diagnosis, surgical treatment and pharmacotherapeutic targets.|
|Keywords:||pathogenesis; treatment; sleep apnoea syndrome|
|Rights:||© 2010 The Authors|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.